ISRCTN40815027
Active, not recruiting
未知
Verification of urinary Xpert bladder cancer detection test in patients with haematuria
niversity of Dundee0 sites600 target enrollmentDecember 23, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Suspected bladder cancer
- Sponsor
- niversity of Dundee
- Enrollment
- 600
- Status
- Active, not recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Adults over the age of 18
- •2\. Presenting with visible and non\-visible haematuria within 12 weeks of the consent visit
- •3\. Scheduled for a standard of care cystoscopy
- •4\. Agrees to provide voided urine for trial purposes
- •5\. Able to consent
Exclusion Criteria
- •1\. Previous diagnosis of bladder cancer
- •2\. Previous history of kidney stone
- •3\. Indwelling urethral catheter
- •4\. Ongoing urinary tract infection
- •5\. Not able to consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]EUCTR2011-001819-30-DESanochemia Pharmazeutika AG220
Active, not recruiting
Not Applicable
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]EUCTR2011-001819-30-ATSanochemia Pharmazeutika AG220
Completed
Phase 2
Detection of non-muscle invasive bladder cancer using PVP-Hypericin (Vidon®) fluorescence cystoscopy(Hypericin PDD)C67Malignant neoplasm of bladderDRKS00003324Sanochemia Pharmazeutika AG227
Not yet recruiting
Not Applicable
Diagnosis of bladder cancer using probe-based confocal laser endomicroscopyBladder CancerJPRN-UMIN000021067Depatment of Urology, Kyoto Prefectural University of Medicine50
Completed
Not Applicable
Xpert bladder cancer monitor test for bladder cancer surveillanceon-muscle invasive bladder cancerCancerNon-muscle invasive bladder cancerISRCTN37210907Medical University Innsbruck150